Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension Article

Zhang, Tiantian, Liang, Zhuoru, Lin, Tengfei et al. (2022). Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension . BMC MEDICINE, 20(1), 10.1186/s12916-022-02601-z

Open Access International Collaboration

cited authors

  • Zhang, Tiantian; Liang, Zhuoru; Lin, Tengfei; Cohen, David J; Arrieta, Alejandro; Wang, Xiaobin; Qin, Xianhui; Wang, Binyan; Huo, Yong; Liu, Gordon G; Jiang, Jie; Zhang, Zugui

sustainable development goals

authors

publication date

  • October 25, 2022

published in

keywords

  • ADULTS
  • BLOOD-PRESSURE
  • CARDIOVASCULAR-DISEASE
  • CHINA
  • Cost-effectiveness
  • EFFICACY
  • Folic acid
  • GLOBAL BURDEN
  • General & Internal Medicine
  • Hypertension
  • Life Sciences & Biomedicine
  • MORTALITY
  • Medicine, General & Internal
  • Primary prevention
  • QUALITY-OF-LIFE
  • RISK
  • STATIN TREATMENT
  • Science & Technology
  • Stroke

Digital Object Identifier (DOI)

publisher

  • BMC

volume

  • 20

issue

  • 1